These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 11103248

  • 21. [A case of advanced gastric cancer with Virchow's and paraaortic lymph node metastases successfully resected after combined chemotherapy of low-dose CDDP and 5-FU].
    Wada Y, Kamiya N, Asano S, Shinya F.
    Gan To Kagaku Ryoho; 2001 Jan; 28(1):79-82. PubMed ID: 11201385
    [Abstract] [Full Text] [Related]

  • 22. [Combination therapy of 5-FU and low dose CDDP for advanced and recurrence gastric cancer].
    Chung YS, Yamashita Y, Nakata B, Nitta A, Inoue T, Hirayama K, Ogawa M, Kubo T, Kato Y, Shirasaka T.
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):149-51. PubMed ID: 7826072
    [No Abstract] [Full Text] [Related]

  • 23. [Chemotherapy with nedaplatin for an oral floor cancer patient undergoing chronic hemodialysis].
    Iwasaki A, Tanizaki A, Ohbayashi Y, Miyake M, Nagahata S, Takahashi N.
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2231-4. PubMed ID: 11142167
    [Abstract] [Full Text] [Related]

  • 24. Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.
    Popov I, Radosevic-Jelic L, Jezdic S, Milovic M, Borojevic N, Stojanovic S, Stankovic V, Josifovski T, Kezic I.
    J BUON; 2008 Dec; 13(4):505-11. PubMed ID: 19145671
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Absorption of 5-FU orally administered in a patient with postoperative gastric cancer under artificial dialysis].
    Tamura J, Kamano T, Azuma N, Katami A, Sato T, Uchida N, Kanno T, Sato T, Kiyatake I, Kakuhara T.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2771-4. PubMed ID: 3631976
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Concurrent low-dose cisplatin/5-FU chemotherapy and radiation for the recurrent gastric carcinoma--case reports].
    Gohongi T, Iida H, Nakai R, Gunji N, Orii K.
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):989-92. PubMed ID: 16835494
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Pharmacokinetics of cisplatin and vindesine in a patient with chronic renal failure undergoing hemodialysis].
    Ayabe H, Uchikawa T, Kimino K, Tagawa Y, Kawahara K, Tomita M.
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3283-5. PubMed ID: 2782920
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Intermittent FLDP: 24-h infusion of 5-FU on days 1, 3 and 5 combined with low-dose cisplatin on days 1-5 for gastric cancer, and its pharmacologic and kinetic rationale.
    Terashima M, Irinoda T, Kawamura H, Takagane A, Abe K, Oyama K, Fujiwara H, Saito K, Gotoh M, Shirasaka T.
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):240-6. PubMed ID: 12655443
    [Abstract] [Full Text] [Related]

  • 34. [Chemotherapy with consecutive low-dose CDDP combined with 5-FU for gynecologic malignancies].
    Shimizu Y, Hasumi K.
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1564-74. PubMed ID: 10553414
    [Abstract] [Full Text] [Related]

  • 35. [Treatment with 5-FU modulated by low-dose CDDP for advanced cancers and recurrent cases of metastasis].
    Shinkai K, Kida H, Hisano H, Shibasaki S, Yano H, Nomura M.
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):329-32. PubMed ID: 10065096
    [Abstract] [Full Text] [Related]

  • 36. [Three cases of advanced gastric cancer treated by TS-1 in combination with low-dose cisplatinum].
    Gomi T, Ohtoshi M, Tamaki N, Momoi H, Kanaya S, Katayama T, Wada Y.
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):301-4. PubMed ID: 11865638
    [Abstract] [Full Text] [Related]

  • 37. [A patient with advanced gastric cancer surviving for more than 5 years after neoadjuvant chemotherapy and curative resection].
    Hirota M, Kimura J, Eguchi T, Kato K, Kobayashi H, Kanazumi N, Suzuki Y, Ishii M.
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):125-9. PubMed ID: 11816468
    [Abstract] [Full Text] [Related]

  • 38. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T, Masuda H, Naito M, Tamai H.
    Anticancer Res; 2001 Jan; 21(4A):2463-9. PubMed ID: 11724308
    [Abstract] [Full Text] [Related]

  • 39. [Clinical experience of intermittent administration of 5-FU and CDDP to patients with advanced and recurrent gastric cancer].
    Sekikawa K, Anzai K, Ishihata R, Yamaki T, Ohki S, Kimijima I, Takenoshita S.
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):825-8. PubMed ID: 11432352
    [Abstract] [Full Text] [Related]

  • 40. [Theoretical basis for low-dose CDDP/5-FU therapy].
    Kubota T.
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1536-41. PubMed ID: 10553409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.